BMI1 and osteosarcoma: Interestingly, a recent report demonstrated that BMI-1 functioned as an oncogene in osteosarcoma and overexpression of BMI-1 promoted cell growth and resistance to cisplatin treatment in osteosarcoma through PI3K/AKT pathway [51].